Nicardipine in the treatment of aneurysmal subarachnoid haemorrhage: A meta-analysis of published data

Acta Neurologica Belgica

Volumn 113, Issue 1, 2013, Pages 3-6

  Huang, Ren Qiang ^a   Jiang, Fu Gang ^a   Feng, Zi Min ^a   Wang, Tian Yi ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Delayed cerebral ischaemia; Meta analysis; Nicardipine; Subarachnoid haemorrhage

Indexed keywords

EID: 84874969414     PISSN: 03009009     EISSN: 22402993     Source Type: Journal    
DOI: 10.1007/s13760-012-0142-x     Document Type: Article

References (23)

1. Barker FG II, Ogilvy CS (1996) Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a meta-analysis. J Neurosurg 84: 405-414.
2. Barth M, Capelle HH, Weidauer S et al (2007) Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid haemorrhage: a prospective, randomized, double-blind phase IIa study. Stroke 38: 330-336.
3. Dorhout Mees SM, Rinkel GJ, Feigin VL et al (2007) Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 3: CD000277.
4. Epstein BJ, Vogel K, Palmer BF (2007) Dihydropyridine calcium channel antagonists in the management of hypertension. Drugs 67: 1309-1327.
5. Haley EC Jr, Kassell NF, Torner JC (1993) A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid haemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 78: 537-547.
6. Harrod CG, Bendok BR, Batjer HH (2005) Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: a review. Neurosurgery 56: 633-654.
7. Hedges LV (1994) Fixed effects models. In: Cooper H, Hedges LV (eds) The handbook of research synthesis. Russell Sage Foundation, New York, pp 285-299.
8. Huang J, van Gelder JM (2002) The probability of sudden death from rupture of intracranial aneurysms: a meta-analysis. Neurosurgery 51: 1101-1105.
9. Kasuya H (2011) Clinical trial of nicardipine prolonged-release implants for preventing cerebral vasospasm: multicenter cooperative study in Tokyo. Acta Neurochir Suppl 110: 165-167.
10. Kasuya H, Onda H, Sasahara A et al (2005) Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid haemorrhage. Neurosurgery 56: 895-902.
11. Keyrouz SG, Diringer MN (2007) Clinical review: prevention and therapy of vasospasm in subarachnoid haemorrhage. Crit Care 4: 211-220.
12. Krischek B, Kasuya H, Onda H et al (2007) Nicardipine prolonged-release implants for preventing cerebral vasospasm after subarachnoid haemorrhage: effect and outcome in the first 100 patients. Neurol Med Chir (Tokyo) 47: 389-394.
13. Lee KH, Lukovits T, Friedman JA (2006) "Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage. Neurocrit Care 4: 68-76.
14. Liu-Deryke X, Rhoney DH (2006) Cerebral vasospasm after aneurysmal subarachnoid haemorrhage: an overview of pharmacologic management. Pharmacotherapy 26: 182-203.
15. Raudenbush SW (1994) Random effects models. In: Cooper H, Hedges LV (eds) The handbook of research synthesis. Russell Sage Foundation, New York, pp 301-321.
16. Rinkel GJ (2008) Medical management of patients with aneurysmal subarachnoid haemorrhage. Int J Stroke 3: 193-204.
17. Rinkel GJE, Feigin VL, ALGRA A et al (2005) Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 1: CD000277.
18. Sabbatini M, Strocchi P, Amenta F (1995) Nicardipine and treatment of cerebrovascular diseases with particular reference to hypertension-related disorders. Clin Exp Hypertens 17: 719-750.
19. Tejada JG, Taylor RA, Ugurel MS et al (2007) Safety and feasibility of intra-arterial nicardipine for the treatment of subarachnoid haemorrhage-associated vasospasm: initial clinical experience with high-dose infusions. AJNR Am J Neuroradiol 28: 844-848.
20. van Gijn J, Rinkel GJ (2001) Subarachnoid haemorrhage: diagnosis, causes and management. Brain 124: 249-278.
21. Wang J, Ho L, Chen L et al (2007) Valsartan lowers brain β-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. J Clin Invest 117: 3393-3402.
22. Weyer GW, Nolan CP, Macdonald RL (2006) Evidence-based cerebral vasospasm management. Neurosurg Focus 21: E8.
23. Zhao XD, Zhou YT, Zhang X et al (2010) A meta analysis of treating subarachnoid hemorrhage with magnesium sulfate. J Clin Neurosci 16: 1394-1397.